Phosphoglycerate kinase 1 deficiency
Revisado por pares por Patient clinician teamÚltima actualización por Dr Chloe Borton, MRCGPÚltima actualización 12 Jun 2009
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Agregar a fuentes preferidas en Google
Esta página ha sido archivada.
No se ha revisado recientemente y no está actualizado. Los enlaces externos y las referencias pueden ya no funcionar.
Profesionales Médicos
Los artículos de Referencia Profesional están diseñados para ser utilizados por profesionales de la salud. Están escritos por médicos del Reino Unido y se basan en evidencia de investigación, así como en guías del Reino Unido y Europa. Puede encontrar uno de nuestros artículos de salud más útil.
En este artículo:
Synonyms: Phosphoglycerokinase deficiency, PGK deficiency, PGK1 deficiency, Haemolytic anaemia with PGK Deficiency,
Phosphoglycerate kinase deficiency is a hereditary metabolic disease. Phosphoglycerate kinase (PGK1) is a ubiquitous glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate generating one molecule of ATP. Its gene lies on the X-chromosome (locus Xq13) and there are related pseudogenes on the X-chromosome and chromosome 19.1
It is a complex enzyme: several subtypes of deficiency have been identified,2 based on the tissues in which the enzyme deficiency occurs and the type of inheritance. Clinically, there are two distinct syndromes:
A pure muscle syndrome characterized by recurrent cramps and muscle breakdown in response to intense exercise.3
A "muscle plus" syndrome which may feature mental retardation and/or haemolytic anaemia.
Different mutations of the erythrocyte enzyme PGK1 gene have been identified but the reason for the multifarious clinical manifestations of mutations of the same gene remains unknown.4
Continúa leyendo abajo
Epidemiología
It is extremely rare.
The gene encoding the erythrocyte enzyme PGK1 is X-linked and PGK is transmitted as an X-linked recessive disorder in nearly 75%. Females are carriers and have a 50% chance of transmitting the gene to an affected son or a carrier daughter. Affected males produce carrier daughters and unaffected sons.
It is inherited as an autosomal recessive in about 25%.5
Presentación
Volver al contenidoPresentation is variable but occurs between infancy and adolescence.
Clinical findings include:
Muscle pain and weakness
Rust-coloured urine after vigorous exercise due to myoglobinuria
Other features are rare and highly variable but may include:
Nausea after exercise
Variable degrees of mental retardation
Seizures
Haemolytic anaemia
Some patients may have a purely myopathic syndrome with progressive proximal muscle weakness and episodes of myoglobinuria, exercise intolerance and easy fatigue.
There can be emotional lability, aphasia with impaired ability to comprehend speech or writing and hemiplegia.
Female carriers may have haemolytic anaemia.
Continúa leyendo abajo
Diagnóstico diferencial
Volver al contenidoThere are a number of enzyme defects that can cause myoglobinuria6 as well as other causes to remember:
Biochemical abnormalities (eg hipopotasemia, hypophosphataemia)
Myopathies
McArdle's disease (Glycogen storage disorder V) and Tarui's disease (Glycogen storage disorder VII)
Acetyl-CoA dehydrogenase deficiency and lactate dehydrogenase deficiency
Polimiositis y dermatomiositis
Malignant hyperthermia
Síndrome neuroléptico maligno
Crush syndrome
Muscle ischaemia secondary to arterial occlusion or insufficiency
Septicemia
Drug abuse
Investigaciones
Volver al contenidoDiagnostic testing is available for the absence of the enzyme phosphoglycerate kinase.
There is recurrent myoglobinuria, especially after exercise.
Serum CK levels are high or normal.
Anaerobic exercise produces no rise in lactate.
Gene mutation identification within family groups.
Continúa leyendo abajo
Manejo
Volver al contenidoNon-Drug
Strenuous exercise should be avoided.
Medicamentos
None are of proven value.
Cirugía
Splenectomy can reduce the haemolytic anaemia and the need for transfusion.7
Complicaciones
Volver al contenidoMyoglobinuria from prolonged exercise can produce renal damage.
Pronóstico
Volver al contenidoSeverity varies but the myopathic syndrome is usually slowly progressive. In one study of a large family, many sufferers died before reaching adulthood.8
Prevención
Volver al contenidoIdentification of the gene9 may permit prenatal diagnosis with a view to termination of pregnancy.
Actualizaciones exclusivas para profesionales de la salud
Mantente informado con las últimas actualizaciones clínicas, perspectivas profesionales y orientación basada en evidencia. El boletín de Patient Pro selecciona contenido esencial para profesionales de la salud, entregado directamente en tu bandeja de entrada.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Lecturas adicionales y referencias
- Phosphoglycerate Kinase-1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
- Tsujino S, Shanske S, DiMauro S; Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency. Muscle Nerve. 1995;3:S45-9.
- Spiegel R, Gomez EA, Akman HO, et al; Myopathic form of phosphoglycerate kinase (PGK) deficiency: A new case and pathogenic considerations. Neuromuscul Disord. 2009 Jan 19.
- Beutler E; PGK deficiency. Br J Haematol. 2007 Jan;136(1):3-11.
- Phosphoglycerate Kinase (PGK) 1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
- Tonin P, Lewis P, Servidei S, et al; Metabolic causes of myoglobinuria. Ann Neurol. 1990 Feb;27(2):181-5.
- Fujii H, Miwa S; Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency. Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):141-8.
- Turner G, Fletcher J, Elber J, et al; Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br J Haematol. 1995 Sep;91(1):60-5.
- Flanagan JM, Rhodes M, Wilson M, et al; The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006 Jul;134(2):233-7. Epub 2006 Jun 1.
Continúa leyendo abajo
Sobre el autor

Dr Chloe Borton, MRCGP
BA, PGCE, MBBS, DFFP, MRCGP
Acerca del revisorVer biografía completa

Equipo de clínicos y pacientes
El equipo clínico de Patient.info crea y revisa nuestro contenido de salud para garantizar que sea preciso, basado en evidencia y guiado por los estándares confiables del NHS y NICE.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
12 Jun 2009 | Última versión

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita